These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10566000)

  • 1. SDZ RAD. Rapamycin SDZ.
    Drugs R D; 1999 Jan; 1(1):97-9. PubMed ID: 10566000
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
    Drugs R D; 1999 Jan; 1(1):100-7. PubMed ID: 10566001
    [No Abstract]   [Full Text] [Related]  

  • 3. Leflunomide. Arava, HWA 486, SU 101.
    Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
    [No Abstract]   [Full Text] [Related]  

  • 4. Early clinical experience with a novel rapamycin derivative.
    Nashan B
    Ther Drug Monit; 2002 Feb; 24(1):53-8. PubMed ID: 11805723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
    Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.
    Viklický O; Zou H; Müller V; Lacha J; Szabó A; Heemann U
    Transplantation; 2000 Feb; 69(4):497-502. PubMed ID: 10708101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
    Hausen B; Boeke K; Berry GJ; Segarra IT; Christians U; Morris RE
    J Heart Lung Transplant; 1999 Feb; 18(2):150-9. PubMed ID: 10194039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTI 322. Anti-CD2 monoclonal antibody, Lo-CD2-a, monoclonal antibody Lo-CD2-a.
    Drugs R D; 1999 Jan; 1(1):68-70. PubMed ID: 10565990
    [No Abstract]   [Full Text] [Related]  

  • 9. Everolimus: a review of its use in renal and cardiac transplantation.
    Dunn C; Croom KF
    Drugs; 2006; 66(4):547-70. PubMed ID: 16597167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
    Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
    Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
    Schuurman HJ; Schuler W; Ringers J; Jonker M
    Transplant Proc; 1998 Aug; 30(5):2198-9. PubMed ID: 9723439
    [No Abstract]   [Full Text] [Related]  

  • 12. Inolimomab. Anti-CD25 monoclonal antibody B-B10, anti-interleukin-2 receptor monoclonal antibody B-B10, B-B10, BT 563, Leukotac.
    Drugs R D; 1999 Jan; 1(1):81-4. PubMed ID: 10565995
    [No Abstract]   [Full Text] [Related]  

  • 13. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
    Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
    Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
    Hausen B; Boeke K; Berry GJ; Christians U; Schüler W; Morris RE
    Ann Thorac Surg; 2000 Mar; 69(3):904-9. PubMed ID: 10750781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Everolimus].
    Michels G; Hoppe UC
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2263-5. PubMed ID: 16208601
    [No Abstract]   [Full Text] [Related]  

  • 16. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
    Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W
    Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHH 380. Chimeric anti-CD7 antibody, SDZ CHH 380.
    Drugs R D; 1999 Jan; 1(1):73-4. PubMed ID: 10565992
    [No Abstract]   [Full Text] [Related]  

  • 18. Everolimus. Novartis.
    Dumont FJ
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1220-34. PubMed ID: 11717808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A drug safety evaluation of everolimus in kidney transplantation.
    Holdaas H; Midtvedt K; Åsberg A
    Expert Opin Drug Saf; 2012 Nov; 11(6):1013-22. PubMed ID: 22954349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus-induced lymphedema in a renal transplant recipient: a case report.
    Ersoy A; Koca N
    Exp Clin Transplant; 2012 Jun; 10(3):296-8. PubMed ID: 22631070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.